Cargando…

Response to Dr. Okumura

Detalles Bibliográficos
Autores principales:	Yamanouchi, Yoshio, Sukegawa, Tsuruhei, Inagaki, Ataru, Inada, Toshiya, Yoshio, Takashi, Yoshimura, Reiji, Iwata, Nakao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492779/ https://www.ncbi.nlm.nih.gov/pubmed/28371917 http://dx.doi.org/10.1093/ijnp/pyx020

Ejemplares similares

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
por: Sukegawa, Tsuruhei, et al.
Publicado: (2014)

Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
por: Yamanouchi, Yoshio, et al.
Publicado: (2015)

Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura
por: Cooper, Edwin L.
Publicado: (2004)

Complete mitochondrial genome sequence of Macromia daimoji Okumura, 1949 (Odonata: Macromiidae)
por: Kim, Min Jee, et al.
Publicado: (2018)

The impact of COVID-19 on inpatient wards at psychiatric hospitals in Japan
por: Usuda, Kentaro, et al.
Publicado: (2021)

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Response to Dr Fried & Dr Kievit, and Dr Malhi et al.
por: Schmaal, L, et al.
Publicado: (2016)

Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence
por: Kishi, Taro, et al.
Publicado: (2011)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Response to Dr. Zimmern
por: Stemerding, Dirk
Publicado: (2010)

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
por: Yoshimura, Reiji, et al.
Publicado: (2019)

DR. PARMANAND KULHARA'S RESPONSE
por: Kulhara, Parmnand
Publicado: (1998)

In Response to Dr. Steven Sorscher
por: Zhang, Shannon S., et al.
Publicado: (2022)

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Reply to Letter from Dr. Tokudome
por: Sugimura, Takashi
Publicado: (1989)

Letter to Editor in response to Dr. Gupta
por: Erdem, Hakan, et al.
Publicado: (2021)

Response to the letter of Dr. Ian Desouza
por: Farré, Jerónimo, et al.
Publicado: (2023)

Response to Dr. DiCarlo‐Cohen
por: Williams, Jacqueline P.
Publicado: (2023)

Lack of Association Between Prokineticin 2 Gene and Japanese Methamphetamine Dependence
por: Kishi, Taro, et al.
Publicado: (2011)

Response to the letter from Dr J. Wang
por: Yuan, Z., et al.
Publicado: (2020)

Response to Letter by Dr. Mammi et al.
Publicado: (2021)

Response to Letter From Dr. Thorakkal Shamim
por: Hotez, Peter J.
Publicado: (2023)

Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses
por: Kishi, Taro, et al.
Publicado: (2018)

Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials
por: Furukawa, Toshi A, et al.
Publicado: (2002)

Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
por: Iwata, Nakao, et al.
Publicado: (2020)

No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis
por: Tsunoka, Tomoko, et al.
Publicado: (2011)

LETTER TO THE EDITOR: Response to the Letter by Dr. Julio Collazos
por: Fortún, J
Publicado: (2010)

Validation of proposed risk stratification system for in‐hospital cardiac complications in patients with takotsubo syndrome
por: Kato, Ken, et al.
Publicado: (2016)

Heart Valve Surgery in Patients with Patent Coronary Artery Bypass Grafts
por: Misawa, Yoshio, et al.
Publicado: (2018)

New‐onset atrial fibrillation after atrial ischemia
por: Kondo, Yusuke, et al.
Publicado: (2019)

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

Response from Dr. Cridge, et al. to Dr. Steiner, et al. letter to editor regarding JVIM_15039
Publicado: (2018)

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
por: Nagao, Kei, et al.
Publicado: (2013)

Response to Dr. DF Naude
por: Alschuler, Lise
Publicado: (2022)

Response to Dr. Strote (letter)
por: Iserson, Kenneth V.
Publicado: (2022)

Two cases of eosinophilic pustular folliculitis associated with pregnancy
por: Matsudate, Yoshihiro, et al.
Publicado: (2016)

Clinical significance of genetic polymorphisms of interleukin-1β and cytochrome P450 2C19 on the eradication of Helicobacter pylori
por: Karbalaei, Mohsen, et al.
Publicado: (2023)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
por: Kishi, Taro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qs0rr7ig51sik7h1iba5pvt1v1